HR Execs on the Move

Ehave

www.ehave.com

 
Ehave is empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis, and treatment. With Ehave Connect, Ehave’s mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems (“MHS”), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder (“ADHD”), through its ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.ehave.com
  • 250 University Avenue Suite 200
    Toronto, ON CAN M5H 3E5
  • Phone: 954.233.3511

Executives

Name Title Contact Details

Similar Companies

Lansinoh Laboratories Inc

Lansinoh Laboratories Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Alexandria, VA. To find more information about Lansinoh Laboratories Inc, please visit www.lansinoh.com

Americana Dental Inc

Americana Dental Inc is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EHE Health

EHE is America`s leading prevention company. We work with major clients from diverse fields to help their employees reach optimal health through comprehensive exams and year-round mentoring and resources. Our holistic, personalized approach improves longevity, productivity, and performance. For more than 100 years, EHE has led the way in preventive health care. We continue to grow and innovate, providing individuals with what they need to feel their best every day.

GL Engineering

GL Engineering is a Livingston, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scynexis

SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.